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 Neisseria gonorrhoeae is an obligate human pathogen that causes the common STI 
gonorrhea, which presents a growing threat to global health. The WHO estimated 78 million 
new cases of gonorrhea worldwide in 2017, with estimates of 820,000 new cases in the United 
States alone according to the CDC. High-frequency phase and antigenic variation inherent in N. 
gonorrhoeae, coupled with its natural ability to rapidly acquire and stably integrate 
antimicrobial resistance factors into its genome, have culminated in an infection against which 
there is no effective vaccine, and for which the list of viable therapeutic options is quickly 
 xiv 
shrinking. Moreover, no protective immunity against subsequent infections is elicited upon 
exposure to N. gonorrhoeae, which highlights the need for research of novel antimicrobial and 
vaccination strategies. Within the human host, N. gonorrhoeae utilizes a unique strategy to 
overcome host sequestration of essential nutrients – termed nutritional immunity (NI) – such as 
ions of trace metals. The pathogen produces a family of outer membrane proteins called TonB-
dependent transporters (TdTs) capable of binding to host NI factors and stripping them of their 
nutritional cargo for use by the pathogen. Importantly, these TdTs are very highly conserved 
and expressed among Neisseria species. TbpA is a well-characterized TdT that allows N. 
gonorrhoeae to acquire iron from human transferrin, and recent studies from our lab have 
shown that TdfH is capable of binding to a zinc-sequestering S100 protein called calprotectin 
and stripping it of its zinc ion. The S100 proteins are EF-hand calcium-binding proteins that 
naturally play an integral role in Ca2+ homeostasis, but due to their ability to bind transition 
metals, they have also demonstrated an innate immunity role by participating in nutrient 
sequestration. 
 The S100 proteins are expressed in all human cells, and all are capable of binding 
transition metals including zinc, manganese, and cobalt. Calprotectin, S100A7, and S100A12 
have demonstrated an ability to hinder the infection potential of pathogenic E. coli, S. aureus, C. 
albicans, and various other pathogens via zinc sequestration. Herein, we demonstrate that N. 
gonorrhoeae is able to overcome this phenomenon and actually utilize these proteins as a zinc 
source in vitro. Furthermore, we identify S100A7 as the specific ligand for TdfJ, which utilizes 
this ligand to internalize zinc during infection. S100A7 growth support in vitro is dependent 
upon a functional TonB, TdfJ, and the cognate ABC transport system ZnuABC, and isogenic 
 xv 
mutants incapable of producing znuA or tdfJ recover S100A7 utilization by complementation. 
Whole-cell binding assays and affinity pulldowns show that S100A7 binds specifically to both 
gonococcal and recombinant TdfJ, and growth and binding experiments show that these 
described phenomena are specific to human and not mouse S100A7. Finally, we show that a 
His-Asn double mutant S100A7 that is incapable of binding zinc cannot be utilized for growth by 
gonococci. These data illustrate the unique nature of the gonococcus’ ability to co-opt host 
defense strategies for its own purposes, and further identify the TdTs as promising targets for 
strategies to combat and prevent gonococcal infection. 
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Introduction 
 
I. Genus Neisseria 
The Neisseria belong to the family Neisseriaceae, a subset of the phylum Proteobacteria 
that also contains such genera as Kingella and Acinetobacter, among others (1). Neisseria are 
Gram-negative diplococci that are known to colonize mucosal surfaces of many animals, 
including humans (2). The Neisseria are nonmotile apart from twitching motility, do not 
produce endospores, are oxidase positive, and achieve optimum growth at 37qC and 5% CO2.  
While most members of genus Neisseria are commensal bacteria commonly found in the 
human flora, two known pathogenic species, N. meningitidis and N. gonorrhoeae, commonly 
infect humans. In some cases, N. lactamica can act as an opportunistic pathogen (3). N. 
gonorrhoeae causes the eponymous STI gonorrhea and is not part of the normal flora. Rather, 
the disease manifests after infection of the mucosa during vaginal, oral, or anal sex (4). As a 
commensal bacterium, N. meningitidis is carried as part of the human naso- and oropharyngeal 
mucosa and can cause severe disease upon dissemination.  
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II. Neisseria gonorrhoeae 
A. Infection 
Neisseria gonorrhoeae primarily infects nonciliated epithelial cells of the urogenital mucosa. 
However, infection of the oro- and nasopharynx has also been observed (10). The mechanisms 
used to accomplish infection show gender specificity (6). The initial binding to mucosal epithelia 
is mediated primarily by the gonococcal type IV pilus, allowing attachment to polarized 
epithelial cells. This interaction is then mediated by invasion proteins such as the opacity 
proteins and porins, which allow the gonococcus to be engulfed by cytoskeletal rearrangements 
and membrane ruffling (7-8). After internalization, gonococci are able to persist intracellularly 
and eventually transcytose the cell, exiting via the basolateral membrane (9). Subsequent 
infection of subepithelial and endothelial cells facilitates N. gonorrhoeae entering the 
bloodstream and disseminating to other areas of the body. Thus, both localized and systemic 
infections are possible. For dissemination to be possible, the gonococcus must evade killing by 
host serum factors including complement, which is partially accomplished by the bacteria 
binding to human factor H, an inhibitor of the alternative complement pathway (11). This 
binding of factor H contributes to the gonococcus’ ability to disseminate and be stable in 
serum. 
B. Disease and Epidemiology 
N. gonorrhoeae is the etiological agent of the STI gonorrhea. Infection can occur in both 
men and women, with infections in men presenting as purulent discharge and dysuria, and 
ascension leading to such complications as epididymitis, prostatitis, and urethritis. In women, 
serious manifestations such as cervicitis, pelvic inflammatory disease (PID), infertility, and 
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ectopic pregnancy can occur (4), and frighteningly, approximately 80% of infected women are 
asymptomatic (12). If left untreated, gonococcal infection can be serious or even life-
threatening, as disseminated infection may occur (5). Disseminated infection occurs in roughly 
1% of infected persons and presents as skin lesions at the extremities and synovial arthritis in 
wrists and ankles (13).  Infected women may pass gonorrhea to their newborns if they are 
exposed to the pathogen in the birth canal. In newborns, N. gonorrhoeae can cause opthalmia 
neonatorum, a serious eye infection that, if left untreated, can lead to blindness (14). A key 
hallmark of gonococcal infection is that it confers no protective immunity against subsequent 
exposure to the pathogen (4).  
Gonorrhea is a growing threat to global health. In 2017 the WHO estimated over 100 million 
new cases of gonorrhea worldwide (15), with 820,000 new cases occurring in the United States 
each year according to the CDC (16), making it the second most commonly reported STI behind 
chlamydia (17). Due to underreporting of the disease in less developed countries, global 
estimates may be low, perhaps underestimated by as much as 50% (18). The most susceptible 
populations are young adults and minorities, especially those that are lower on the 
socioeconomic scale. In the USA, the highest incidence of gonococcal disease is reported in 
southern states, with infection most common in African Americans, Native Americans, and 
Hispanics, especially those between 15-24 years of age. Rates are similar between men and 
women (18). Gonorrhea has implications for other diseases as well, as up to 30% of patients 
diagnosed with gonorrhea are also infected with chlamydia (13), and gonococcal infection has 
been associated with an increased amount of HIV shedding from the genital tract, making HIV-
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infected persons who are also infected with gonorrhea more likely to spread HIV than someone 
infected with HIV alone (19). 
C. Treatment and Vaccination 
The current recommended treatment for gonococcal infection is dual therapy - one single 
intramuscular injection of 250mg ceftriaxone and 1g azithromycin taken orally (20). Rapid 
acquisition of antibiotic resistance among gonococcal isolates means that the list of available 
treatment options is rapidly shrinking. The last few decades have seen N. gonorrhoeae increase 
frequency of resistance to quinolones, and strains of gonococci showing decreased 
susceptibility to third-generation cephalosporins are currently being identified (21-22). In fact, 
2007 marked the end of any fluoroquinolones being prescribed as treatment for gonorrhea. 
Even more frighteningly, a 2018 case of gonococcal disease isolated in the United Kingdom 
exhibited high levels of resistance to the current recommended dual therapy (23).  
There is no effective vaccination against infection by N. gonorrhoeae. Infection does elicit a 
strong inflammatory response, but no protective immunity results (28). Moreover, effective 
cross protection by vaccines against N. meningititis is not confirmed. The gonococcus is a 
paradigm for high frequency phase and antigenic variation, creating a bacterial surface that 
exists in a constant state of flux and thus making identification of vaccine targets extremely 
difficult (24). The best model for antigenic variation in N. gonorrhoeae comes from the type IV 
pilus. This variation is mediated by non-reciprocal recombination of silent loci into the single 
gonococcal expression locus of pilin, pilE. Estimates of pilin antigenic variation range from 10-2 
to 10-4 variants per CFU, with roughly 107 pilin variants possible (25). Attempts at pilin-based 
vaccination against gonorrhea have been unsuccessful, as a vaccine composed of a single pilus 
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type elicited an immune response but failed to protect against gonococcal urethritis (26). A 
well-described model for phase variation exists in the Opacity (Opa) proteins of N. 
gonorrhoeae. The Opa proteins are invasins that interact with human CEACAMs, and are 
susceptible to stochastic DNA strand slippage at pentameric repeats (29). This slippage has the 
potential to knock Opa transcripts out of the correct reading frame, causing cessation of protein 
production (27). Other genes susceptible to strand slippage see changes in promoter strength 
and polymerase/ribosome binding. Current promising candidates for gonococcal vaccine 
development are a group of outer membrane transporters called TonB-dependent transporters 
(TdTs). These proteins play a key role in nutrient acquisition and are well conserved across 
gonococcal isolates.  
III. Metal Acquisition 
A. Iron 
Almost all microorganisms require iron for survival. In the bacterial cell, iron plays a key role 
as a cofactor in many enzymatic reactions, and N. gonorrhoeae is no exception. Thus, as an 
invading pathogen, the gonococcus is susceptible to growth inhibition in environments 
containing a prohibitively low iron concentration. The human host, by use of high-affinity iron 
carrier proteins, restricts the serum iron concentration to approximately 10-24 M (30), owing 
partially to the fact that free iron can be toxic to cells. In terms of immunity, this iron 
sequestration has the effect of starving invading pathogens of the essential nutrient, a 
phenomenon often referred to as nutritional immunity (31). Pathogens have evolved certain 
mechanisms to overcome nutritional immunity, most commonly by the production of high-
affinity non-ribosomally produced chelating compounds called siderophores, which are capable 
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of outcompeting host proteins for iron (32). Critically, N. gonorrhoeae does not produce 
siderophores, and instead employs an arsenal of TonB-dependent transporters (TdTs) capable 
of binding directly to host nutritional immunity proteins and stripping them of their metal cargo 
(33). The TdTs all consist of a β-barrel consisting of 22 amphipathic β strands, and a globular 
plug domain to occlude the barrel when not transporting cargo (36). The gonococcus produces 
eight known TdTs (Fig. 1), of which four are known to play a role in iron acquisition (34). The 
best characterized of these is TbpA, which allows acquisition of iron from human transferrin 
with the help of TbpB. All gonococcal isolates identified to date possess genes for production of 
TbpAB, but mutant strains incapable of producing these proteins are incapable of growth on 
human transferrin as a sole iron source (37). Human transferrin is a serum glycoprotein 
responsible for binding and transporting iron and is ~30% saturated with iron in vivo (35). The 
current model of TbpA utilization of transferrin-iron involves binding of human transferrin by 
TbpA with help by TbpB, whereupon iron is extracted from transferrin and interacts with the 
plug domain of TbpA. At this point, the TonB protein uses the proton motive force to alter the 
plug in a manner that promotes iron release into the periplasm, freeing it to be transported the 
rest of the way into the cell by a cognate ABC transport system (discussed below) (34). The 
basic mechanism for iron internalization is the same for the other two-component TdTs of N. 
gonorrhoeae, LbpA and HpuB. LbpA allows the gonococcus to utilize human lactoferrin as a sole 
iron source, but about half of gonococcal isolates have lost the ability to produce the protein 
(38). N. gonorrhoeae does not have a dedicated transport system for free heme, but the HpuB 
protein allows the pathogen to utilize heme bound to hemoglobin as a source of iron (39). 
Unlike Tbp and Lbp, the HpuAB system does not exclusively recognize human hemoglobin, but 
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can in fact recognize those from other mammals as well (34). The fourth iron-centric TdT of N. 
gonorrhoeae is FetA. Unlike the three transporters already discussed, FetA has no associated 
lipoprotein to aid in uptake efficiency. FetA has been shown to increase binding and acquisition 
of enterobactin when expressed (40). The siderophore enterobactin is a produced by several 
other bacteria and apparently can be co-opted by the gonococcus, as can other siderophores 
including salmochelin (41) and dihydroxybenzoylserine (34). Two additional TdTs, TdfF and 
TdfG, are as yet incompletely characterized. Like FetA and the other Tdfs (discussed in the next 
section), these two proteins lack a surface-associated lipoprotein, and both show regulation by 
metal ions as they are repressed by iron (47-48). TdfF is present in all pathogenic Neisseriae but 
not commensals (49), and its absence has been shown to contribute to growth defects within 
epithelial cells (47). TdfG is the largest TdT identified in Neisseria at 136kDa, and is almost 
completely exclusive to N. gonorrhoeae (49). 
B. Zinc 
Like iron, zinc is an essential cofactor in many enzymatic reactions critical to the survival of 
bacteria, such as oxidation-reduction and nucleoside biosynthesis. As such, bacterial pathogens 
have evolved several mechanisms of ensuring they maintain an adequate supply of this key 
element (42). Unsurprisingly, N. gonorrhoeae produces two TdTs that help the pathogen 
acquire zinc: TdfH and TdfJ (43-44). TdfH and TdfJ do not feature a surface-tethered lipoprotein. 
TdfH and TdfJ are repressed by zinc, which is consistent with the expected phenotype of a zinc 
transporter. TdfJ additionally is induced by iron-replete conditions. It has recently been shown 
that TdfH enables N. gonorrhoeae to utilize human calprotectin as a sole source of zinc in vitro.  
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Figure 1. TonB-dependent transporters and their associated lipoproteins and ABC transport 
systems produced by Neisseria gonorrhoeae. The TonB-dependent transporters (TdTs) of N. 
gonorrhoeaea are essential for acquiring metals such as iron and zinc. TbpA, LbpA, HpuB, and 
their associated surface-tethered lipoproteins, allow the pathogen to strip iron from human 
transferrin, lactoferrin, and hemoglobin, respectively. FetA strips iron from xenosiderophores of 
other bacteria. TdfH was recently shown to remove zinc from human Calprotectin, and TdfJ 
binds to free zinc. No ligand for TdfF or TdfG has been identified. (64) 
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The gonococcus binds directly to calprotectin in a TdfH-dependent manner and internalizes zinc 
via TonB and ABC transport (43). TdfJ is expressed by all Neisseriae (44). The N. meningitidis 
homologue of TdfJ, named ZnuD, has been shown to participate in both zinc and heme 
utilization, and is regulated by both zur and fur (45). Moreover, in a mouse model ZnuD was 
required to cause systemic infections by the meningococcus, and X-ray crystallography shows 
that free zinc ions bind directly to ZnuD (46).  
C. ABC Transport of Metals 
The aforementioned TdTs all rely on a cognate ABC transport system for completion of 
metal internalization by the bacterium. Once iron and zinc have passed through the outer 
membrane via one of the TdTs, they are bound by periplasmic binding proteins. These proteins 
then dock with permeases in the cytoplasmic membrane, which is energized by hydrolysis of 
ATP, allowing the ions to finally enter the cell. Tbp, Lbp, and Hpu are serviced by FbpABC, which 
demonstrates high-affinity iron transport (50), while ZnuABC (51) transports zinc and is 
functionally associated with TdfH and TdfJ (44). ZnuABC has also been shown to play a role in 
transport of manganese and is elsewhere in the literature referred to as MntABC (52).  The 
FetBCD system allows internalization of enterobactin associated with FetA (40). 
 
IV. S100 Proteins 
An interesting contributor to nutritional immunity are the S100 proteins. The S100 family is 
made up of 24 members divided into three groups separated by the location of their functions: 
intracellular only, extracellular only, or both intra- and extracellular. These proteins are 
expressed only in vertebrates, and expression patterns vary depending on cell and tissue type. 
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While S100 proteins have been implicated as regulators of differentiation, apoptosis, 
inflammation, and other pathways (58), their primary function in eukaryotic cells is 
maintenance of calcium signaling and homeostasis (53). The S100 proteins all feature a calcium 
binding EF-hand motif (54), which consists of a helix-loop-helix structure typically present in 
pairs that are held together by antiparallel β strands. The S100 proteins preferentially form 
dimers, an action that sterically affects one of the helices in the motif, making it very rigid upon 
calcium binding (55). Additionally, the dimer interface of the S100 proteins, which can be 
hetero- or homodimeric in nature, allows for the high affinity binding of transition metals such 
as Zn, Mn, and Cu (56) (Fig. 2). Binding of zinc by S100B was first described in 1984 (57), and 
since then other members of the S100 family including S100A7 (psoriasin), S100A12 
(calgranulin C), and the S100A8/A9 heterodimer (calprotecin) have also demonstrated high-
affinity zinc binding. Structural analyses revealed that two His-rich, symmetrically disposed 
binding pockets within the dimeric forms of these proteins facilitate this interaction (59). 
Furthermore, one of the binding pockets of calprotectin has demonstrated the ability to bind 
manganese. This metal binding ability coupled with calprotectin’s high expression levels in 
neutrophils contributes to killing of invading pathogens via nutrient sequestration (60-61). 
Indeed, this mechanism is not unique to calprotectin, as S100A7 has demonstrated similar 
killing effects for E. coli, S. aureus, and P. aeruginosa (62), and S100A12 has been implicated in 
host defense against parasites by the same mechanism (63). Perhaps unsurprisingly, N. 
gonorrhoeae has evolved a method of overcoming calprotectin-mediated nutritional immunity 
akin to those described for transferrin and others. Gonococcal TdfH binds calprotectin and 
strips it of its zinc, which is then internalized for use by the pathogen. This allows the  
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Figure 2. S100 family proteins involved in nutritional immunity. S100 proteins are obligate 
homo- or heterodimers dimers, consisting of subunits which oligomerize in the presence of 
micromolar concentrations of calcium. Shown above are the structures of a few members of 
the S100 family that have been implicated in nutritional immunity. (A) S100A7 bound to zinc. 
(B) S100A12 bound to copper. (C) Calprotectin bound to zinc and manganese. 
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gonococcus to survive in neutrophil NETs in vitro (43.)  Based on the structural similarity of the 
gonococcal TdTs and that of the S100 family of proteins, coupled with the ability of S100s to 
bind transition metals that also regulate the TdTs, and with knowledge of an existing system for 
TdT-mediated zinc uptake from calprotectin, it is hypothesized that study of the other S100 
proteins may contribute to identification of other human ligands for the TdTs, and ultimately 
further clarify the TdT’s potential as promising vaccine and antimicrobial targets.  
V. Research Objectives 
To further characterize the gonococcal TdTs, specifically the Tdfs, and evaluate their 
potential as vaccine candidates, we have developed the following aims for this study: 
Aim 1. Screen zinc-binding S100 proteins for the ability to support growth of N. gonorrhoeae 
as a sole zinc source, and evaluate whether any observed growth is dependent upon the Tdfs 
 N. gonorrhoeae has already proven itself capable of utilizing zinc bound to calprotectin 
as a sole zinc source in vitro courtesy of TdfH (43), and the similarly zinc-regulated ZnuD is 
known to bind directly to a zinc ion (46) and shows remarkable sequence identity with TdfJ, 
which suggests that this TdT is likewise associated with zinc uptake. To evaluate whether this 
potential uptake is associated with S100 proteins, these potential ligands will be saturated with 
zinc and presented to the gonococcus as a sole zinc source and growth support will be 
evaluated. In the event a potential interaction is identified, biophysical tests to assess binding, 
specificity, and zinc internalization will be performed. 
  
 15 
 
Aim 2. Evaluate the contribution of ZnuABC to Tdf-associated zinc uptake. 
 ZnuABC binds to both zinc and manganese (51-52). The specific ligand for TdfH, 
calprotectin, likewise binds to zinc and manganese (56). This is consistent with the hypothesis 
that a functional ZnuABC is required for TdfH-mediated zinc internalization, as well as for any 
potential TdfJ-mediated zinc uptake. To assess the requirement for ZnuABC in this pathway, 
znuA isogenic mutants and complemented strains will be constructed and assessed for their 
ability to sustain Tdf-associated zinc uptake from known and experimental zinc sources. 
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Materials and Methods 
 
I. Bacterial Strains and Growth Conditions 
All strains of N. gonorrhoeae and E. coli utilized in this study are summarized in Table 1. 
Gonococcal strains were maintained on GC medium base (Difco) plates containing Kellogg’s 
supplement 1 and 12μM Fe(NO3)3 (Sigma) (GCB plates). Strain MCV951 was maintained as 
described with additional supplementation of 25μM each of ZnSO4 and MnCl2 and 5mM D-
mannitol (Sigma). MCV954 was maintained as described with addition of 500μM IPTG (Sigma). 
Liquid cultures of gonococci were grown in baffled sidearm flasks (Bellco) in defined medium 
which was pre-treated with Chelex 100 (Bio-Rad) (CDM), with appropriate supplementation for 
MCV951 when needed. Growth in Zn-depleted conditions was accomplished by growing 
cultures in CDM supplemented with 1μM N,N,N,N-Tetrakis (2-pyridylmethyl)-ethylenediamine 
(TPEN) (Sigma). Strains MCV954 and MCV957 were induced with 1mM IPTG during liquid 
growth. Cultures were grown in a 37qC incubator with shaking at 225 RPM and 
supplementation with 5% CO2, and optical density was measured by a Klett™ Colorimeter. E. 
coli strains were grown in Luria-Bertani (LB) broth (Difco) supplemented with 100µg/mL 
carbenicillin, 34µg/mL chloramphenicol, 50µg/mL spectinomycin, or 50µg/mL kanamycin. E. coli  
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Table 1. Strains and Plasmids Used in This Study 
 
Strain/Plasmid         Genotype/Purpose                                                Reference   
E. coli Strains          
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG 
recA1 araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) 
endA1 λ- 
Invitrogen 
NovaBlue endA1 hsdR17 (rK12– mK12+) supE44 thi-1 recA1 gyrA96 relA1 
lac Fʹ[proA+B+ lacIqZΔM15::Tn10] (TetR) 
Novagen 
OverExpress C41 
(DE3)         
F– ompT gal dcm hsdSB(rB- mB-)(DE3)  
 
Lucigen 
 
Gonococcal 
Strains 
  
FA19 Wild-type 107 
MCV925 FA19 tdfF::Ω 79 
MCV926 FA19 tdfG::Ω 79 
MCV927 FA19 tdfH::Ω 79 
MCV928 FA19 tdfJ::Ω 79 
MCV650 FA19 tonB::Ω 108 
MCV951 FA19 znuA::Ω from pVCU551 This study 
MCV952 FA19 transformed with pVCU553 This study 
MCV954 MCV952 transformed with pVCU551 This study 
MCV957 MCV928 transformed with pVCU554 This study 
 
Plasmids   
pET11a Expression vector Novagen 
pVCU403 pUC18 + GC uptake sequence 109 
pKH37 Complementation vector 82 
pVCU234 pKH37 + Shine-Dalgarno Sequence 111 
pVCU313 pBAD TOPO + tdfJ 110 
pUNCH1321 pET11a + tdfF 110 
pVCU550 pVCU403 + znuA fragment This study 
pVCU551 pVCU550 + Ω cassette (znuA::Ω) This study 
pVCU552 pCR2.1 TOPO + znuA This study 
pVCU553 pVCU234 + znuA This study 
pVCU554 pVCU234 + tdfJ This study 
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liquid cultures were grown at 37qC overnight with shaking at 225 RPM, and those maintained 
on agar plates were incubated at 37qC overnight. 
 
II. Molecular Techniques 
PCR was performed using either high-fidelity Taq-based polymerases (Invitrogen) or 
Phusion polymerase (New England Biolabs) accompanied by primers synthesized by Integrated 
DNA Technologies. All primers used in this study are listed in Table 2. PCR products were 
purified using a Nucleospin® Gel and PCR Clean-up Kit (Macherey-Nagel) and either cloned 
directly into the pCR2.1-TOPO vector (Invitrogen) according to manufacturer instructions, or 
cloned directly into their destination vector by utilization of the In-Fusion® Cloning System 
(Clontech). All restriction endonucleases used were purchased from New England Biolabs, and 
restriction fragments were purified from agarose gels via a QIAquick Gel Extraction kit (Qiagen). 
Linearized vectors were treated with recombinant shrimp alkaline phosphatase (NEB) to 
remove unwanted 5’ phosphates prior to ligation of DNA fragments by T4 DNA ligase (NEB). 
Ligations were incubated overnight at room temperature prior to heat inactivation of the ligase 
and subsequent transformation of chemically competent E. coli. Plasmid DNA was recovered 
from E. coli broth cultures by using a QIAprep Spin miniprep kit (Qiagen). 
 
III. Mutant Construction 
To construct an isogenic FA19 mutant strain unable to produce ZnuA, primers oVCU865 and 
oVCU866 were used to amplify a region of the znuA gene from a chromosomal prep of strain 
FA19. The resulting PCR product was purified and ligated into the EcoRI site of pVCU403 (109) 
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via the In-Fusion® cloning method. This ligation mixture was used to transform TOP10 
(Invitrogen) E. coli and transformants were selected on 50µg/mL carbenicillin and confirmed by 
PCR to generate pVCU550. To disrupt the znuA gene, an Ω cassette (SpcR StrR) was ligated into 
the BmgB1 site of the znuA fragment from pVCU550 with T4 DNA ligase. This ligation was used 
to transform Novablue (EMD Millipore) E. coli and transformants were selected on 50µg/mL 
spectinomycin and confirmed by PCR. The resulting plasmid, pVCU551 (Fig. 3), was linearized 
with SspI and used to transform a piliated population of gonococcal strain FA19, creating 
MCV951 which was confirmed by PCR. Recovery of these transformants required GCB plates 
supplemented with 25μM each of Zn and Mn plus 5mM D-mannitol, in addition to selection on 
50µg/mL spectinomycin. To generate an IPTG inducible znuA complement, primers oVCU893 
and oVCU894 were used to amplify the full znuA gene from FA19, which was then purified and 
subcloned into pCR2.1 TOPO according to manufacturer instructions and used to transform 
TOP10 E. coli. The resulting plasmid, pVCU552, was digested with XmaI and HindIII to excise the 
znuA gene, which was then ligated with T4 DNA ligase into pVCU234 (111) that had previously 
been linearized with the same enzymes. pVCU234 inserts into an ectopic site of the gonococcal 
chromosome between the aspC and lctP loci. This plasmid was used to transform Novablue E. 
coli with selection on 34µg/mL chloramphenicol and the product plasmid pVCU553 was 
confirmed by PCR and sequencing. pVCU553 was linearized with PciI and used to transform 
piliated FA19, selecting on GCB plates plus 1µg/mL chloramphenicol, creating a partial diploid 
for znuA. This strain, named MCV552, was then transformed with linearized pVCU551 to 
retroactively disrupt the native znuA locus, with transformants selected on GCB plates 
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supplemented with 50µg/mL spectinomycin and 500μM IPTG (Fig. 4). The resultant strain, 
MCV954,  
Table 2. Primers Used in This Study 
 
Primer               Sequence                                                      Purpose   
oVCU865 CTCTAGAGGATCCCCCACCTCAAACTTACCCTTAT znuA Disruption Fragment 
Forward 
oVCU866 CCATGATTACGAATTGCCGAGTGCGTCGGAATA znuA Disruption Fragment 
Reverse 
oVCU893 CCCGGGCACAGGAAAACAGTTATGAA znuA Complement 
Forward 
oVCU894 AAGCTTTTATTGCTTCATCGCGTTGGTCTT znuA Complement Reverse 
oVCU967 TTAAAAGGAGCCCGGGATGCGACGAGAAGCCAAAATGG tdfJ Complement Forward 
oVCU968 CGGGCCCCCCCTCGAGAAACTTCACGTTTACGCCGCC tdfJ Complement Reverse 
oVCU173 GGCACCCAGCCTGCGCGAGCAGGGG Ω Cassette Outward (Left) 
oVCU174 CGCAACATCCGCATTAAAATCTAGCGAGGG Ω Cassette Outward 
(Right) 
oVCU900SM CACGAACCCAGTGGACATAA Ω Cassette Forward 
oVCU901SM GGGACAACGTAAGCACTACA Ω Cassette Reverse 
oVCU816 CTAGGCACCCCAGGCTTTACAC pKH37 Sequencing 
oVCU896 CAGACCGTTCAGCTGGATATT CAT Marker Forward 
oVCU897 CCTTGTCGCCTTGCGTATAA CAT Marker Reverse 
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Figure 3. Schematic of construction of znuA null mutant MCV951. Primers oVCU865 and 
oVCU866 were used to amplify a region of the znuA gene which was ligated into the EcoRI site 
of pVCU403 via the In-Fusion® cloning method to generate pVCU550. To disrupt the znuA gene, 
an Ω cassette (SpcR StrR) was ligated into the BmgB1 site of the znuA fragment from pVCU550 
with T4 DNA ligase. The resulting plasmid, pVCU551, was linearized with SspI and used to 
transform a piliated population of gonococcal strain FA19, creating MCV951, which was 
selected on 50µg/mL spectinomycin and 25μM each of zinc and manganese. 
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Figure 4. Schematic representation of the construction of a znuA complemented strain 
MCV954. Primers oVCU893 and oVCU894 were used to amplify the full znuA gene from FA19, 
which was then subcloned into pCR2.1 TOPO. The resulting plasmid, pVCU552, was digested 
with XmaI and HindIII to excise the znuA gene, which was then ligated with T4 DNA ligase into 
pVCU234 to make pVCU553. pVCU553 was linearized with PciI and used to transform piliated 
FA19, selecting on GCB plates plus 1µg/mL chloramphenicol, creating a partial diploid for znuA. 
This strain, named MCV552, was then transformed with linearized pVCU551 to retroactively 
disrupt the native znuA locus, with transformants selected on GCB plates supplemented with 
50µg/mL spectinomycin and 500μM IPTG. The resultant strain, MCV954, was confirmed by PCR 
and Southern blotting. 
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Figure 5. Schematic of construction of tdfJ complemented strain MCV957. Primers oVCU967 
and oVCU968 were used to amplify the full tdfJ gene, and generated a PCR product with 5’ 
15bp overhangs which were complementary to flanking regions of the complementation vector 
pVCU234, which inserts into an ectopic site in the gonococcal chromosome between the aspC 
and lctP loci. The PCR product was ligated into the XmaI and XhoI sites of pVCU234 via In-
Fusion® cloning to make pVCU554, which was then linearized with PciI and used to transform 
MCV928. The resulting gonococcal strain, MCV957, was selected on 1µg/mL chloramphenicol 
and is inducible with 1mM IPTG. 
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was confirmed by PCR and Southern blotting. Finally, to create an IPTG-inducible tdfJ 
complement, primers oVCU967 and oVCU968 were used to amplify the full tdfJ gene from 
FA19, which was cloned via In-Fusion® into pVCU234 that had been linearized with XmaI and 
XhoI and used to transform TOP10 E. coli. Transformants were selected on 34µg/mL 
chloramphenicol and confirmed by PCR and sequencing. This plasmid pVCU554 was linearized 
with PciI and used to transform piliated MCV928 (79), and transformants were selected on 
1µg/mL chloramphenicol. The resulting strain MCV957 was confirmed by PCR and by recovery 
of S100A7 utilization upon IPTG induction (Fig. 5). 
 
IV. Southern Blotting 
Southern analysis of the znuA loci of FA19, MCV951, MCV952, and MCV954 was performed 
to confirm the genetic identity of MCV954. Chromosomal preps of these four strains were 
digested with ClaI and fully separated on a TBE-agarose gel. The gel was then transferred to an 
HDPE dish and covered with 0.25N HCl for 10 minutes. The gel was then denatured in 1.5M 
NaCl, .5N NaOH for 1h with gentle agitation. The gel was then rinsed briefly with dH2O and 
washed with a solution of 0.5M Tris pH 7.0, 1.5M NaCl with gentle agitation 1h. Meanwhile, 
two sheets of nylon membrane and four sheets of 3MM paper were pre-soaked in 5X SSPE. 
After gel washing was complete, bi-directional transfer of DNA was performed at room 
temperature overnight. The next day, membranes were removed and UV-crosslinked with a 
Stratagene UV Stratalinker 2400 and added to pre-hybridization buffer (5X SSC, 1% (w/v) 
salmon sperm DNA, 0.1% N-lauroylsarcosine, .02% SDS) in a sealed plastic bag and incubated in 
a 68qC water bath for 1h. After 1h, pre-hybridization solution was replaced with hybridization 
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solution (as described above plus freshly-boiled PCR probe) and incubated again at 68qC with 
agitation overnight. The next day, filters were washed with excess 2X SSC + .1% SDS, then 
washed again at 68qC with excess .1X SSC +.01% SDS. Detection was performed with a Biotin 
Chromogenic Detection Kit (Thermo) according to the manufacturer. PCR probes were 
generated for znuA and the Ω cassette by PCR amplifying the aforementioned pieces, and were 
then biotinylated with a Biotin DecaLabel DNA Labeling Kit (Thermo) according to instructions. 
 
V.Metal Loading of Proteins 
Human transferrin (hTf) was dissolved in initial buffer (100mM Tris, 150mM NaCl, 20mM 
NaHCO3, pH 8.4) prior to incubation with FeCl2 at molar ratios that allow ~30% hTf saturation by 
Fe. This solution was then added to Slide-A-Lyzer™ dialysis cassettes (Thermo) and dialyzed 
against excess dialysis buffer (40mM Tris, 150mM NaCl, 20mM NaHCO3, pH 7.4) for 4 hours at 
room temperature followed by overnight dialysis at 4qC in fresh buffer. The Fe-bound hTf was 
then removed via syringe and filter sterilized. S100 proteins were maintained in their own 
unique buffers that were present upon arrival from Dr. Chazin’s lab and were loaded to ~50% 
saturation with Zn by incubation with ZnSO4 diluted in phosphate buffered saline (PBS). This 
solution was combined in PBS with 30% Fe-hTf, bovine apo-transferrin (bTf), and TPEN to create 
a gonococcal growth “premix” which was used to restrict available zinc sources to only the S100 
protein present in the growth premix. Positive control premix was made by omitting TPEN and 
replacing the zinc-loaded S100 protein with ZnSO4 alone. Negative control premix was made by 
omitting any zinc source from the mix. Premixes were made as a 10X stock, and when diluted 
by gonococcal liquid culture, final concentrations of ingredients are as follows: 7.5μM 30% Fe-
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hTf, 3μM bTf, 5μM zinc source (S100 or ZnSO4), 1μM TPEN. A slight variant of this recipe was 
constructed to be compatible with strain MCV650, as it is unable to utilize iron bound to 
transferrin. In this case, bTf was omitted from the recipe, and hTf was replaced with 30μM 
Fe(NO3)3 (3μM final in solution). 
 
VI. Growth of Gonococci with Zinc-bound S100 Proteins 
Gonococci were grown in Zn-restricted CDM as described until exponential phase, at which 
point 100µL samples were added to the wells of a 96-well microtiter dish and OD600 was 
measured using a Molecular Devices Vmax kinetic microplate reader. Aliquots of liquid cultures 
were then diluted in CDM to OD600 =.02 and were used to inoculate wells of the microtiter dish 
that were pre-loaded with concentrated premix prepared as described above, and bringing the 
total volume in the wells to 100µL. In some experiments, αTdfJ IgG/sera or pre-immune 
IgG/sera was added to premix in amounts equimolar to the S100 protein present. At this point, 
another OD600 reading was taken and the plate was then incubated for 6h at 37qC with shaking 
at 225 RPM. OD measurements were taken every 2h, and graphs of data points and associated 
statistical analyses were performed in Graphpad Prism 7.  
 
VII. Assay of Zinc Internalization 
Gonococcal cultures were grown as described in Zn-restricted rich medium as described 
until doubling. After doubling, cultures were diluted and treated with 2μM S100A7 that had 
been pre-incubated with 1μM ZnSO4, and 1mM IPTG was added if appropriate. After 6h, 
cultures were harvested by centrifugation at 3750 RCF for 10 minutes. The pellet was washed 
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with 5mL cold, Chelex-treated PBS treated with 1mM EDTA. Culture was then centrifuged and 
washed again for a total of two washes. This sample was added to a 15mL metal-free conical 
tube with 1mL set aside for protein quantification. Remaining sample was centrifuged again as 
described and the pellet was stored overnight at -20qC. After overnight freezing, samples were 
resuspended in a minimal volume of trace-metal grade (67-70%) nitric acid and transferred to 
1.5mL microfuge tubes, following which they were heated to 95qC for 2h for acid digestion. 
After digestion, samples were transferred back to 15mL metal free conical tubes and diluted to 
5% HNO3 using Chelex-treated dH2O. These samples were submitted for inductively coupled 
plasma optical emission spectrometry (ICP-OES) and trace metal profile was determined against 
a standard curve ranging from 5 to 4000ppb.  
 
VIII. Whole-cell Binding Assays 
S100A7 was dialyzed against excess dialysis buffer that had been modified by replacing Tris 
with 40mM HEPES. The protein was then conjugated to HRP using the HRP conjugation kit 
ab102890 (Abcam) according to the manufacturer’s instructions.  Gonococcal strains FA19, 
MCV928, and MVC957 or E. coli strains carrying pET11a or pVCU313 were grown as described in 
Zn-restricted CDM + IPTG where appropriate and LB + antibiotic, respectively. For E. coli, 1mM 
IPTG and .02% arabinose were added to pET11a and pVCU313, respectively, when OD=.5 was 
reached. Cultures were grown for 4h following induction before standardized culture densities 
were applied to nitrocellulose in a dot blot apparatus for solid-phase binding. Unbound cells 
were washed away with low salt TBS + 0.05% polysorbate 20, and then blocked for 1h in 5% 
(w/v) nonfat milk in TBS. Following blocking, S100A7-HRP was diluted to 0.2μM in blocker, 
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added to samples, and incubated with shaking for 1h. After incubation, samples were washed 
five times with low salt TBS + .05% polysorbate 20 and colorimetric detection was performed. 
For solid phase experiments, detection was performed using a Metal Enhanced DAB Substrate 
Kit (Thermo), or for ELISA by using TMB substrate solution that was stopped by addition of 
.16M H2SO4 and output read by measuring OD420 on a Vmax microplate reader. For competition 
assays, nitrocellulose was treated with bacteria as described above, and S100A7-HRP was 
added simultaneously with either 10-fold molar excess mouse S100A7 (mS100A7) or unlabeled 
human S100A7, and blots incubated were developed as described. 
 
IX. Affinity Pulldowns 
S100A7 was dialyzed against HEPES-based dialysis buffer and then coupled to Affi-Gel® 15 
(Bio-Rad) according to manufacturer instructions. After coupling, remaining unreacted groups 
were blocked by addition of 1M ethanolamine for 1h, followed by washing with the dialysis 
buffer. To generate a control affinity matrix with no conjugate, the Affi-Gel® was incubated 
with 1M ethanolamine only and resuspended in dialysis buffer after washing. E. coli cultures 
carrying pET11a, pVCU313, and pUNCH1321 were grown in LB and induced at OD=~.5. 
Induction was allowed to proceed for 4h, after which cells were pelleted by centrifugation at 
15000 RPM in a Sorvall RC-5B Refrigerated Superspeed Centrifuge. These pellets were then 
solubilized in lysis buffer (.1M Tris, .05M NaCl, 1% Triton X-100, 25μM lysozyme, 25U benzoase 
nuclease, pH 8.0). Solubilized E. coli was then passed over prepared affinity matrices at 
standardized amounts, and matrices were washed with dialysis buffer + 0.05% lauryl-maltoside. 
For specific elution of proteins bound to affinity matrix, the matrix was resuspended in 2X 
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Laemmli buffer containing 5% β-mercaptoethanol and boiled for 5 minutes. This product was 
centrifuged for 1 minute at 10,000 RPM, and the supernatants were submitted to SDS-PAGE 
and Western analysis. 
 
X. SDS-PAGE and Western Analysis 
Strains of N. gonorrhoeae or E. coli were grown as described before. Cultures of 
standardized cell density were collected and pelleted by centrifugation at 13,000 RPM. These 
pellets were resuspended in 100µL 2X Laemmli buffer containing 5% β-mercaptoethanol and 
boiled for 5 minutes. 20µL of sample was then loaded onto 7.5 or 15% polyacrylamide gels 
alongside 5µL Precision Plus Protein™ Markers (Bio-Rad) and run in Tris-Glycine SDS buffer until 
the dye fronts traversed the gel. Protein samples were then transferred to nitrocellulose and 
blots were Ponceau stained to demonstrate equal loading. Blots were then blocked 1h in 5% 
nonfat milk (w/v) in TBS. After blocking, primary antibodies (αTdfJ, αTdfF, or αS100A7) were 
diluted in blocker and added to membrane for 2h. Blots were washed 3X10min before addition 
of secondary antibodies (Goat αGuinea Pig, αRabbit, or αMouse, respectively) for 1h. 
Secondaries were either conjugated to alkaline phosphatase or HRP and all were purchased 
from Abcam. After washing, AP conjugates were developed with NBT-BCIP (Sigma) or ECL 
(Thermo). All chemiluminescent and colorimetric images were recorded using a Bio-Rad 
ChemiDoc Imaging System. 
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Results 
 
I. S100 Proteins Support Growth of Wild-type Neisseria gonorrhoeae When Presented as a 
Sole Zinc Source  
 Neisseria gonorrhoeae utilizes a family of outer membrane proteins called TonB-
dependent transporters (TdTs) in order to acquire essential nutrients from its human host. 
Calprotectin is a member of the S100 family of proteins and has been demonstrated to exhibit 
antimicrobial effects on invading pathogens including Escherichia coli, Staphylococcus aureus, 
and Candida albicans by means of zinc sequestration (60, 61, 66-71). Our lab recently showed 
that the gonococcal TdT TdfH is capable of binding Calprotectin and stripping it of its zinc, which 
is internalized by the pathogen (43). Like Calprotectin, many other members of the S100 
protein family are able to bind zinc (56), so we sought to determine whether additional S100 
proteins were able to act as a zinc source for N. gonorrhoeae in vitro. To assess this, we loaded 
S100 proteins, which had been purified as previously described (60), with zinc at a 2:1 molar 
ratio to accomplish ~25% zinc saturation by weight. These proteins were provided to 
gonococcal strain FA19 as a sole zinc source in zinc-restricted conditions, and growth was 
tracked over 6h. All S100 proteins utilized in this assay, which include S100A2 (72), S100A4 (73), 
S100A6 (74), S100A7 (75), S100A12 (76), and S100B (77), were able to support growth of the  
 34 
 
 
 
 
 
 
 
 
 
Figure 6. Growth support of N. gonorrhoeae by various S100 proteins. Strain FA19 was grown 
in zinc-restricted CDM as described, and was treated with growth premix containing the 
indicated S100 protein that has been pre-treated with zinc. Growth was allowed to proceed for 
6h, with OD600 measurements taken every 2h. A two-way repeated measure ANOVA with 
Tukey’s correction was performed on these data, but due to clutter the results are not shown 
graphically. All S100 proteins except S100A4 reached significance compared to samples treated 
with no zinc. 
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gonococcus when compared to FA19 treated with no zinc, and all except S100A4 reached 
significance (Fig. 6). Calprotectin is known to support growth in this manner (43), so it as well as 
free ZnSO4 were included as positive controls. 
 
II. Strain MCV928 Cannot Utilize S100A7 as a Sole Zinc Source 
 We next wanted to assess whether any of the other Tdfs (F, G, and J) were involved in 
utilization of the S100 proteins, as is the case for TdfH and Calprotectin. To address this, we 
employed strains MCV925, MCV926, and MCV928, which are null mutants for tdfF, tdfG, and 
tdfJ, respectively. These strains were grown as described for strain FA19 and were provided 
with the aforementioned S100 proteins as the zinc source. Strains MCV925 and MCV926 
showed an identical phenotype to strain FA19 (data not shown), while MCV928 was unable to 
grow when S100A7 was the sole zinc source (Fig. 7). This suggests that TdfJ is required for 
S100A7 to be utilized. To confirm this finding, growth with MCV928 was repeated to test only 
S100A7, and the previous result was recapitulated (Fig. 8). In all cases, growth of this strain was 
statistically indistinguishable from samples treated with no zinc. 
 
III. Strain MCV650 Retains Growth Support by S100A12, but is Unable to Utilize S100A7 
 To further explore the role of TdfJ in utilization of S100A7, we performed growth assays 
with gonococcal strain MCV650, which is incapable of producing TonB. Despite TdfJ presence in 
this strain, it will not perform any transport function without a functional TonB (78). When 
MCV650 was grown in zinc-restricted conditions with S100A7 as a zinc source, its optical  
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Figure 7. Neisseria gonorrhoeae requires a functional TdfJ to utilize S100A7 as a sole zinc 
source. Strain MCV928 was grown in zinc restricted CDM as described and treated with growth 
premix supplemented with the designated S100 protein and were grown for 6h, with OD600 
measurements taken every 2h. 
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Figure 8. MCV928 cannot utilize S100A7. (A) The N. gonorrhoeae tdfJ null mutant, MCV928, 
was grown in Zn-restricted CDM supplemented with growth premix containing ZnSO4, S100A7, 
or no zinc. Growth was measured by OD600 readings every 2h for 6h total. A 2-way repeated 
measures ANOVA with Tukey’s correction was performed for all means, with significance at 6h 
shown. *, P ≤. 05; **, P ≤ .005; ***, P ≤ .0005; ****, P ≤ .0001 
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Figure 9. S100A7 utilization during growth depends on TonB. N. gonorrhoeae mutant strain 
MCV650 (tonB) was also grown in Zn-restricted CDM, but to overcome the mutant’s inability to 
utilize iron from human transferrin, growth premix was instead prepared with 3μM Fe(NO3)3 
with iron chelators excluded. Both graphs demonstrate means and SD for n=3 independent 
experiments. A 2-way repeated measures ANOVA with Tukey’s correction was performed for all 
means, with significance at 6h shown. *, P ≤. 05; **, P ≤ .005; ***, P ≤ .0005; ****, P ≤ .0001 
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density at 6 hours was indistinguishable from a strain treated with no zinc (Fig. 9). S100A12, 
which according to previous experiments does not depend on a TdT for growth support, was 
included in this experiment as well for comparison to S100A7. At 6h, samples treated with 
S100A12 reached higher optical densities than seen in samples treated with free zinc, 
suggesting its utilization does not depend on TonB or the TdTs. While a mechanism for this was 
not investigated in these studies, Ton-independent utilization of siderophores by gonococci has 
been described (79).  
 
IV. TdfJ is Zinc Repressed and Iron Induced in Strain FA19 
 Previous reports have established that in strain another wild-type strain, FA1090, TdfJ 
production is repressed by zinc and induced by iron (43), but the regulatory effects of these 
metals were only considered individually and not in concert with each other, and not in strain 
FA19. We sought to identify the regulatory pattern of TdfJ in strain FA19 as concerns these 
metals, both alone and together. We performed Western analysis of whole-cell lysates 
prepared from strain FA19 grown in chemically defined media (CDM) supplemented with zinc, 
iron, and/or the high affinity zinc chelator TPEN at the concentrations indicated (Fig. 10). We 
found that levels of TdfJ were decreased in the presence of zinc and increased in the presence 
of iron. TdfJ production was almost nonexistent when zinc was present and iron absent, which 
agrees with the observed phenotype for FA1090. When grown in iron-rich and zinc-deplete 
conditions, TdfJ production was maximal. We confirmed equal sample loading by Ponceau S, 
and with these results established a set of conditions that are optimal for TdfJ production. 
These conditions were utilized for all experiments requiring maximal expression of the protein. 
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Figure 10. TdfJ is zinc repressed and iron induced. Strain FA19 was grown in CDM until 
exponential growth, then back diluted in the same media and treated with Fe(NO3)3, ZnSO4, 
and/or TPEN in the concentrations indicated. These cultures were grown for 4 hours before 
whole-cell lysates of equalized density were prepared and subjected to SDS-PAGE and 
subsequent immunoblotting with antiserum raised against TdfJ. Ponceau stained blot shows 
equal sample loading. 
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V. S100A7 Utilization is Recovered in an Induced tdfJ Complemented Strain In Vitro 
 Having established that absence of endogenous TdfJ in N. gonorrhoeae resulted in loss 
of growth support by S100A7, we sought to demonstrate IPTG-inducible complementation of 
tdfJ by inserting a functional version of the gene in an ectopic site in the chromosome of 
MCV928. We utilized the In-Fusion® cloning method to insert the full tdfJ sequence into 
pVCU234, which is a modified version of pKH37 containing a consensus Shine-Dalgarno 
sequence (80) as the beginning of the polylinker. pVCU234 contains two copies of the lac 
promoter region (81) and inserts between the aspC and lctP loci (82) in the gonococcal 
chromosome, allowing us to insert the construct directly into the tdfJ null strain MCV928. This 
process is illustrated in figure 5, and strain identity was confirmed by PCR and named MCV957.  
 We next utilized MCV957 in growth assays identical to those previously described to 
determine whether it could recover utilization of S100A7. When induced with 1mM IPTG, 
MCV957 completely recovers the growth phenotype for S100A7 that was observed in the wild-
type, while uninduced samples were indistinguishable from samples grown with no zinc (Fig. 
11). Based on these data in conjunction with data from strains MCV928 and MCV650, we 
concluded that a functional TdfJ is required for S100A7 utilization. 
 
VI. S100A7 Binds Both Gonococcal and Recombinant TdfJ 
 Having established that TdfJ is required for S100A7-dependent growth, we next wanted 
to establish whether a physical protein-protein interaction was present between the two. To 
address this, we grew gonococcal strains FA19, MCV928, and MCV957 with and without IPTG in 
zinc-restricted CDM before bacteria of standardized optical density were applied to a  
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Figure 11. A tdfJ complemented strain, MCV957, recovers S100A7-dependent growth when 
induced. MCV957 was grown as described previously, with S100A7-containing premixes further 
supplemented with either 1mM IPTG or no IPTG. The graph demonstrate means and SD for n=3 
independent experiments. A 2-way repeated measures ANOVA with Tukey’s correction was 
performed for all means, with significance at 6h shown. *, P ≤. 05; **, P ≤ .005; ***, P ≤ .0005; 
****, P ≤ .0001 
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nitrocellulose membrane in a dot blot apparatus. This method allowed us to probe the surface 
of bacterial proteins presenting surface antigens in their native conformation. When probed 
with HRP-labeled S100A7, only strains FA19 and induced MCV957 demonstrated detectable 
binding upon signal development (Fig. 12). These results demonstrate that not only is wild-type 
N. gonorrhoeae capable of directly binding S100A7, but that TdfJ is necessary for this 
interaction. To address the fact that possible disruption of the native gonococcal outer 
membrane may have occurred upon deletion of TdfJ, we wanted to recapitulate these findings 
in E. coli producing recombinant TdfJ. We induced cultures of E. coli harboring either pVCU313 
for tdfJ expression or an empty expression vector pET11a and applied them to nitrocellulose at 
the same optical densities used for gonococci before probing with S100A7-HRP in the same 
manner described above. Only E. coli displaying TdfJ on their surface generated detectable 
signal. 
 
 We next sought to demonstrate these binding interactions by affinity pulldowns. We 
first conjugated S100A7 to Affi-Gel 15® and blocked any unreacted groups by addition of 1M 
ethanolamine, or made a null matrix by blocking all reactive groups without any conjugate 
added. We next induced E. coli containing pVCU313 (tdfJ), pUNCH1321 (tdfF), or empty pET11a 
and passed solubilized lysates of these cultures over the matrices. Specific eluates from the 
matrices were isolated after washing and these fractions were analyzed by SDS-PAGE and 
Western blotting (Fig. 13). TdfJ was specifically eluted from only the matrix conjugated to 
S100A7, and TdfF did not bind this matrix. Neither protein was bound to the null matrix. We 
therefore concluded that S100A7 directly binds TdfJ. 
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Figure 12. S100A7 binds both gonococcal and recombinant TdfJ. N. gonorrhoeae strains FA19, 
MCV928, and MCV957 with and without IPTG were grown as described in Zn-restricted CDM 
supplemented with 24μM Fe(NO3)3 for 4 h before being applied to nitrocellulose in a dot blot 
apparatus at a standardized optical density (top row). E. coli strains containing pVCU313 for 
TdfJ production or carrying an empty pET11a vector were grown in LB and induced for 4h 
before standardizing to the same optical density as used for gonococci and subsequently 
applied to nitrocellulose (bottom right). Samples were blocked and then probed for 1 h with 
HRP-labeled S100A7 diluted in blocker before colorimetric development. Wells lacking culture 
were probed with S100A7-HRP and developed to determine background signal (bottom left). 
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Figure 13. Recombinant TdfJ is specifically eluted from an S100A7-conjugated affinity matrix. 
Solubilized recombinant E. coli strains pVCU313 or pUNCH1321 expressing TdfJ and TdfF, 
respectively, or an empty vector were passed over Affi-Gel 15 affinity matrix conjugated with 
S100A7 or a fully-blocked null matrix with no S100 protein. Nonspecific proteins from lysates 
were removed by washing prior to specific elution and identification by SDS-PAGE and Western 
Blotting.  
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VII. TdfJ Interacts Specifically With the Human Version of S100A7 
 Neisseria gonorrhoeae is an obligate human pathogen, and as such has evolved in many 
ways to specifically interact with the human host (83). We sought to determine whether the 
same was true for the S100A7/TdfJ interaction. The mouse version of S100A7 (mS100A7, 
Abbexa) was loaded with zinc at the same saturation used for the experiments conducted with 
human S100A7 and presented to wild-type FA19 cells as a sole zinc source in otherwise zinc-
depleted media. mS100A7 was completely unable to support growth of gonococci, 
demonstrating optical densities even lower than those samples given no zinc source (Fig 14). As 
mS100A7, like the human version, sequesters zinc, it is feasible that this further diminished 
growth phenotype is due to additional, effective zinc chelation by mS100A7 during the assay as 
there is no mechanism present for the gonococcus to circumvent this.  
In addition to growth restriction, we tested the ability of gonococci and recombinant E. coli to 
physically bind mS100A7 by performing competition assays. FA19, MCV928, and MCV957 with 
and without IPTG, or E. coli expressing tdfJ or an empty vector were dotted onto nitrocellulose 
in standardized amounts before blocking and probing with S100A7-HRP. Simultaneously with 
the ligand, we added 10-fold molar excess of either mS100A7 or unlabeled human S100A7 as 
competitor. As before, only those cultures presenting TdfJ on the surface generated any signal 
from HRP, and only samples treated with human competitor demonstrated signal reduction;  
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Figure 14. TdfJ utilization of S100A7 is specific for the human version of S100A7. Strain FA19 
was grown in Zn-restricted CDM supplemented with growth premix containing ZnSO4, human 
S100A7, mouse S100A7, or no zinc. OD600 readings were taken every 2h for 6h total. Mean and 
SD for n=3 experiments are represented in the graph. A 2-way repeated measures ANOVA with 
Tukey’s correction was performed for all means, with significance at 6h shown. *, P ≤. 05; **, P 
≤ .005; ***, P ≤ .0005; ****, P ≤ .0001  
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Figure 15. TdfJ binds only to the human version of S100A7. Strain FA19 and MCV928 (tdfJ) 
were grown in Zn-restricted CDM supplemented with 24μM Fe(NO3)3 for 4 hours, after which 
equal culture densities were transferred to nitrocellulose in a dot blot apparatus. E. coli 
containing pVCU313 for TdfJ production or an empty pET11a were grown in LB and induced for 
4h before being standardized to the same optical density used for gonococci and applied to 
nitrocellulose. Blots were then blocked and subsequently treated with HRP-labeled S100A7 
either alone or with a 10-fold molar excess of unlabeled mouse or human S100A7 as 
competitor. Following this treatment blots were washed and colorimetric signal detection 
performed. Blots shown are representative of n=3 experiments. 
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mS100A7 did not compete for binding of gonococcal TdfJ (Fig 15). These data are consistent 
with the conclusion that the TdfJ/S100A7 interaction, like other gonococcal surface 
structure/host ligand interactions, is specific to the human host, consistent with N. 
gonorrhoeae’s nature as an obligate human pathogen. 
 
VIII. TdfJ Allows Neisseria gonorrhoeae to Internalize Zinc From S100A7 
 Having demonstrated that S100A7 both binds to TdfJ and supports growth as a zinc 
source, we next wanted to ascertain whether this pathway led to accumulation of zinc within N. 
gonorrhoeae. We grew strains FA19, MCV928, and MCV957 with and without IPTG in zinc-
restricted rich medium in the presence of partially zinc-saturated S100A7 before quantifying 
the amount of zinc assimilation by using inductively coupled plasma optical emission 
spectrometry (ICP-OES). A schematic illustration of the ICP-OES process is shown in Figure 16. 
Zinc concentrations were determined as counts/second measured at 213.857 nm and then 
standardized to reflect µg zinc per mg cellular protein (Fig. 17). Strain FA19 internalized 
significantly more zinc from S100A7 than was seen for MCV928, suggesting TdfJ is necessary for 
this process. IPTG-induced MCV957 similarly showed significantly more zinc assimilation than 
both MCV928 and uninduced MCV957, which agrees with our previous experiments that 
showed complementation of tdfJ recovers both gonococcal binding of and growth support by 
S100A7. These data demonstrate that gonococcal TdfJ interacts with S100A7 in a manner that 
facilitates zinc internalization by the pathogen. 
 
 60 
 
 
 
 
 
 
 
 
 
Figure 16. A schematic representation of the ICP-OES process. 
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Figure 17. TdfJ internalizes zinc from S100A7. Strains FA19, MCV928 (tdfJ), and MCV957 (tdfJC) 
with and without IPTG were grown in Zn-restricted rich medium supplemented with 2uM 
partially-saturated S100A7. After 6h cells were harvested and digested in concentrated TMG 
nitric acid prior to ICP-OES analysis to detect trace metals profile. Data shown are measured 
counts/second read at 213.857nm per mg cellular protein compared to a trace metals standard 
curve ranging from 5 to 4000ppb. N=3 independent cultures. *, P ≤. 05; **, P ≤ .005; ***, P ≤ 
.0005; ****, P ≤ .0001 
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IX. S100A7 Zinc Chelation is Essential for Utilization by TdfJ 
 Lastly, as concerns the TdfJ/S100A7 interaction, we were interested to see if S100A7 
binding zinc specifically is what allows growth support of the gonococcus. Since the S100 
proteins are capable of binding more than just zinc (56), we tested whether other metals may 
play a role in S100A7-mediated growth. We grew strain FA19 in zinc-depleted CDM 
supplemented with a double His-Asn (H87N, H91N) mutant S100A7 (Zn KO S100A7) that is 
unable to bind zinc. This mutant had been previously mixed with ZnSO4 for sufficient time to 
allow zinc loading in the wild-type protein, before being dialyzed against buffer containing 
Chelex-100 to remove unbound metals. The mutant S100A7 showed no ability to support 
gonococcal growth, and was statistically indistinguishable from samples treated with no zinc, 
suggesting zinc presence in S100A7 is key for its role in gonococcal growth. (Fig 18).  
 
X. N. gonorrhoeae Depends on the High-Affinity Zinc Uptake System ZnuABC to Utilize 
S100A7 and the Other S100s. 
 ZnuABC, the high affinity zinc transporter, has been a consistent factor present in Gram-
negative bacteria that employ TdTs to acquire metals (69, 84). We wanted to assess whether 
this was true for the S100A7/TdfJ interaction and for the other S100s as well. We utilized In-
Fusion® cloning to generate a znuA null mutant, MCV951, in the FA19 background. The 
schematic of this mutant’s construction is outlined in figure 3. MCV951 is not a viable strain 
under standard growth conditions, and as such its growth must be supplemented at least with 
5mM D-mannitol, and ideally with 25μM each of zinc and manganese if experiments allow. The  
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Figure 18. Mutant S100A7 unable to bind zinc is deficient in TdfJ-dependent growth support. 
Both wild-type S100A7 and mutant S100A7 incapable of binding zinc were mixed with ZnSO4 at 
a 2:1 molar ratio and incubated with end-over-end mixing for 18h to allow any zinc loading to 
occur. After this, both mixtures were dialyzed against Chelex-100-treated dialysis buffer to 
remove any unbound ions before being utilized in growth premix. Strain FA19 was grown in Zn-
restricted supplemented with premix containing either wild-type or mutant S100A7, with OD600 
readings taken every 2h for 6h total. The graph demonstrates means and SD for n=3 
independent experiments. A 2-way repeated measures ANOVA with Tukey’s correction was 
performed for all means, with significance at 6h shown. *, P ≤. 05; **, P ≤ .005; ***, P ≤ .0005; 
****, P ≤ .0001 
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generally nonviable nature of MCV951 is consistent with previous reports that suggest ZnuABC 
is required for helping bacteria overcome oxidative stress (85-87). In addition, we constructed 
an IPTG-inducible znuA complemented strain, MCV954. As MCV951 is particularly feeble, it is 
not a good candidate for transformation procedures, so construction of MCV954 took multiple 
intermediate steps (Fig. 4). We subcloned the full znuA gene from FA19 into pCR2.1 TOPO 
before transferring it to pVCU234. The resulting plasmid pVCU553 was used to transform FA19 
to create a partial diploid of znuA. This strain then retroactively had its native znuA locus 
disrupted by the same methods used to create MCV951. We assumed there was a 50/50 
chance that the ectopic locus and not the native locus would be disrupted, so we identified the 
correct genotype by Southern blotting, as shown in figure 19.  
 To assess the ability of MCV951 to utilize S100A7, we performed growth assays as 
described previously. When presented with S100A7 as a sole zinc source, MCV951 reached 
lower optical density than seen in samples treated with no zinc, and was significantly lower 
than samples given free zinc (Fig. 20). In addition to S100A7, we tested the other S100 proteins 
in the same manner. The same phenomenon was seen for each of the S100s in question except 
for S100A4, which was not investigated further (Fig. 21). These data suggest that a functional 
ZnuA is necessary for utilization of the S100s, and that those other than A7 are utilized in a Ton-
independent manner. The mechanism for this is not clear and was not pursued in these studies. 
Finally, strain MCV954 was grown as described with and without IPTG to determine whether it 
could recover utilization of S100A7 (Fig. 22).  The other S100s were not tested in this manner. 
When induced with IPTG, MCV954 recovered utilization of S100A7 and reached optical 
densities significantly higher than those seen in samples treated with free zinc.  
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Figure 19. Confirmation of MCV954 by Southern blotting. FA19, MCV951, MCV952, and 
MCV954 chromosomes were digested with ClaI and fully separated on a TBE-agarose gel before 
being transferred to nylon membranes by bidirectional capillary transfer. After transfer, DNA 
was UV crosslinked to the membrane and pre-hybridized with salmon sperm DNA. After pre-
hybridization, membranes were hybridized with freshly denatured biotinylated PCR product of 
either znuA or the Ω morker. After washing, hybridized DNA was detected by probing with 
streptavidin conjugated to alkaline phosphatase. 
 
 
 
 
 
 
 
 
 
 
 
 69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FA19 MCV951 MCV952 MCV954 
D
N
A
 P
ro
be
: z
nu
A 
D
N
A
 P
ro
be
: Ω
  
 70 
 
 
 
 
 
 
 
 
Figure 20. A functional ZnuA is required for growth with S100A7. N. gonorrhoeae mutant 
strain MCV951 (znuA) was grown in Zn-limited conditions in defined media (CDM), which was 
supplemented with growth premix containing either ZnSO4, S100A7, or no zinc. Growth was 
measured by OD600 readings every 2h for 6h total. Graph demonstrates means and SD for n=3 
independent experiments. A 2-way repeated measures ANOVA with Tukey’s correction was 
performed for all means, with significance at 6h shown. *, P ≤. 05; **, P ≤ .005; ***, P ≤ .0005; 
****, P ≤ .0001 
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Figure 21. ZnuA is required for utilization of all S100 proteins except S100A4. N. gonorrhoeae 
mutant strain MCV951 (znuA) was grown in Zn-limited conditions in defined media (CDM), 
which was supplemented with growth premix containing either ZnSO4, an S100 protein, or no 
zinc. Growth was measured by OD600 readings every 2h for 6h total.  
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Figure 22. A functional ZnuA is required for growth with S100A7. N. gonorrhoeae mutant 
strain MCV954 (znuAC) was grown in Zn-limited conditions in defined media (CDM), which was 
supplemented with growth premix containing either ZnSO4, S100A7 with and without IPTG, or 
no zinc. Growth was measured by OD600 readings every 2h for 6h total. Graph demonstrates 
means and SD for n=3 independent experiments. A 2-way repeated measures ANOVA with 
Tukey’s correction was performed for all means, with significance at 6h shown. *, P ≤. 05; **, P 
≤ .005; ***, P ≤ .0005; ****, P ≤ .0001 
 
 
 
 
 
 
 
 
 
 
 
 75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 2 4 6 8
0.00
0.05
0.10
0.15
0.20
MCV954 (znuAC)
Hours
O
D
60
0
5µM Free Zinc
No Zinc
5µM S100A7 +IPTG
5µM S100A7 -IPTG
* 
* 
 76 
 
 
 
 
Discussion 
 
 In the evolving arms race between host and pathogen, a prevalent theme has been 
nutritional immunity, which is the host’s mechanism of restricting the availability of essential 
nutrients from invading pathogens, thus hindering their ability to establish infection. This is 
primarily accomplished by production of scavenging proteins that bind and sequester the 
nutrients in question, making them inaccessible (90). Many essential bacterial processes 
depend on transition metals such as zinc, iron, and manganese, making them key targets for 
this mechanism (88, 89). In response to nutritional immunity efforts, many pathogens have 
evolved the ability to produce and secrete siderophores, which are high-affinity compounds 
capable of out-competing host scavenging proteins and securing metal ions for use by the 
bacteria (91). Unlike most pathogens, however, N. gonorrhoeae does not produce 
siderophores, and is instead capable of overcoming nutritional immunity by non-traditional 
mechanisms. Rather than siderophores, N. gonorrhoeae utilizes an arsenal of outer-membrane 
proteins called TonB-dependent transporters to bind directly to host nutritional immunity 
factors and strip them of their nutritional cargo. Of the eight known gonococcal TdTs, four 
(TbpA, LbpA, HpuB, and FetA) participate in iron acquisition from transferrin, lactoferrin, 
hemoglobin, and xenosiderophores produced by other bacteria, respectively (34). Recently, it 
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has become clear that in addition to iron, the gonococcus has dedicated TdTs this are employed 
in zinc acquisition; TdfH binds to human Calprotectin, and TdfJ was previously shown to bind 
free zinc (43, 44). Upon consideration of the high level of conservation, both structural and 
functional, of the TdTs, we hypothesized that the uncharacterized TdTs may play an important 
role in nutrient acquisition for the gonococcus in the context of host nutritional immunity, 
especially for zinc uptake. Additionally, recent studies have shown these transporters to be 
promising candidates for vaccine development (92, 93).  
 In our attempts to further characterize the TdTs, we turned our attention to the S100 
family of proteins. The S100s are EF hand calcium binding proteins that play many key roles in 
vertebrates, including but not limited to participating in nutritional immunity (65). The 
aforementioned Calprotectin has antimicrobial effects against numerous pathogens by 
sequestering zinc and manganese, and participates in neutrophil bactericidal activity via its 
presence in NETs (60, 61). Indeed, other members of the S100 family have demonstrated 
similar antimicrobial mechanisms. Like Calprotectin, S100A7 and S100A12, commonly referred 
to as psoriasin and calgranulin C, respectively, contribute to killing of S. aureus, P. aeruginosa, S. 
flexneri, H. pylori, and C. albicans by sequestering zinc (65, 76, 94-99). While antimicrobial 
activity is not reported for all of the S100s, metal binding is a constant, so we looked beyond 
just the three proteins described above. In these studies, we found that when loaded with zinc, 
the S100 family proteins were capable of serving as a zinc source for N. gonorrhoeae in defined 
media, suggesting that the pathogen is able to co-opt these proteins which, in many cases are 
antimicrobial. 
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 Having established that these proteins were indeed sufficient zinc sources, and knowing 
that TdfH binds Calprotectin, we decided to screen the other Tdfs (TdfF, TdfG, TdfJ) as potential 
receptors for the S100s in question. These experiments revealed that in the absence of TdfJ, 
growth was not supported by S100A7, suggesting that these proteins may be interacting 
partners during gonococcal infection. In addition, we constructed an IPTG-inducible tdfJ 
complemented strain that, when induced, completely recovered the S100A7-zinc growth 
phenotype. We went on to show that S100A7 growth support depends on TonB, which aligns 
with the hypothesis that it is a partner for TdfJ, and in conjunction with data from our induced 
complement, suggests that a functional (TonB active) TdfJ is sufficient for N. gonorrhoeae to 
use S100A7 as a sole zinc source. It is important to note that the tonB mutant utilized in this 
study is not able to use transferrin as an iron source, which was the preferred source for our 
assay. To circumvent this, we replaced transferrin with Fe(NO3)3, which is not utilized as readily 
as transferrin, so overall bacterial growth was in general lower for these experiments. All other 
growth experiments leading up to this point were repeated with this replacement iron source 
and all growth patterns were recapitulated (data not shown). Of the S100 proteins queried in 
this study, only Calprotectin and S100A7 were unable to support growth in the absence of 
TonB, which is the expected result for Tdf ligands.   
TdfJ acting as a zinc importer is not unexpected, as its meningococcal homologue ZnuD 
has been shown to bind extracellular zinc (44), and TdfJ is regulated by the Zur regulator (100) 
and has been shown to contribute to gonococcal growth in zinc-restricted conditions (101, 
102). These results are corroborated by our own experiments pertaining to the regulation of 
tdfJ expression. Jean et al (43) showed that in gonococcal strain FA1090, TdfJ production was 
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repressed by zinc presence and induced by iron, but these metals were only considered 
individually and not in concert with each other. We expanded these studies to FA19 and 
assessed whether zinc absence and iron presence had a combined effect on TdfJ. We found 
that like FA1090, FA19 TdfJ is zinc repressed and iron induced, and that when both conditions 
are met, TdfJ production is maximal. These conditions were applied to all experiments requiring 
TdfJ production.  
 We next turned our attention towards asking whether TdfJ and S100A7 directly 
interacted with each other to facilitate the observed growth phenotype. Our data showed, via 
two approaches, that these two proteins directly bind to each other both when TdfJ is 
expressed on the cell surface and when purified. When gonococcal cultures were grown in 
conditions optimal for TdfJ production, both FA19 and the induced tdfJ complement, MCV957, 
were able to directly bind S100A7 in whole-cell solid-phase binding experiments. Gonococci 
lacking TdfJ on their surface generated no detectable binding, suggesting that a direct protein-
protein interaction exists. Moreover, the growth conditions used are also ideal for production 
of the related zinc transporter TdfH, so this protein was present on the outer membrane as 
well. The lack of S100A7 binding to tdfJ mutant strains that still express a functional TdfH 
indicates that this interaction is indeed specific for TdfJ and not just TdTs in general. We 
considered the possibility that inactivating the tdfJ gene, which encodes a membrane-
embedded protein, may have generated unexpected, unintended alterations to the outer 
membrane as a whole, and thus potentially confound binding experiments. To address this, we 
probed recombinant E. coli expressing either gonococcal TdfJ or containing an empty vector 
and found that TdfJ presence alone is sufficient for S100A7 binding, thus confirming their 
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interaction. In addition to whole-cell binding assays, we also utilized affinity pulldowns in an 
attempt to specifically elute TdfJ from an affinity matrix that had S100A7 conjugated to it. Only 
when passed over a matrix presenting S100A7 was recombinant TdfJ present in the specific 
eluate, and when another TdT, TdfF, was passed over this matrix, S100A7 did not bind. From 
these data, we conclude that S100A7 is the specific ligand for TdfJ and that they directly bind 
each other. 
 As an obligate human pathogen, N. gonorrhoeae utilizes many virulence factors that are 
restricted to the human host (83). Relevant TdT examples include TbpA exclusively binding 
human transferrin and TdfH only binding human Calprotectin. By utilizing mouse S100A7 
(mS100A7) in whole-cell binding assays, we demonstrated that both gonococcal and 
recombinant TdfJ bind only to the human version of S100A7, and do not interact with the 
mouse version. While mouse S100A7 shares only 34% sequence identity with its human 
counterpart, its expression patterns, structure, and function are similar in both mice and 
humans (103, 104). Even when present at 10-fold molar excess, mS100A7 shows no ability to 
compete for binding. In identical growth experiments as performed previously, we showed also 
that when presented to the gonococcus as a zinc source, mS100A7 is unable to support 
bacterial growth, and indeed seems to directly hinder growth. We anticipate this is due to 
mouse S100A7 chelating the remaining free zinc from the growth medium, which is then 
unavailable to the pathogen. Taken together, these data show that TdfJ’s interaction with 
S100A7 is specific to the human host, which agrees with previous reports on TdT/host 
interaction.  
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 Finally, we moved our attention towards clarifying the fate of zinc in the TdfJ/S100A7 
system. TdfH internalizes zinc from Calprotectin (43), but zinc internalization is not seen with its 
meningococcal homologue CbpA (102), so it was unclear which would be true for TdfJ. We 
utilized inductively coupled plasma optical emission spectrometry to quantify the amount of 
cellular zinc in gonococcal strains growth with S100A7 as a sole zinc source. We found that 
gonococci presenting a functional TdfJ accumulated significantly more internal zinc than strains 
not producing this protein, suggesting that the binding of S100A7 by TdfJ directly leads to zinc 
internalization, aligning with the activity of TdfH towards Calprotectin. To complement these 
data, we employed a mutant version of S100A7 in which two of the four zinc chelating histidine 
residues were mutagenized to asparagine, thus rendering the protein defective for zinc 
chelation. When this protein was incubated with same concentration of zinc as was present for 
saturation of wild-type S100A7 and subsequently used as a zinc source for N. gonorrhoeae in 
vitro, it showed significantly reduced growth support compared to the wild-type protein and 
was statistically indistinguishable from cultures grown with no zinc. These experiments 
demonstrate that the ability of S100A7 to bind zinc specifically is what allows it to support 
gonococcal growth, and that other transition metals seemingly do not play a role.  
 Having demonstrated that TdfJ utilizes S100A7 for the purpose of zinc internalization, 
we next wanted to elucidate how the zinc ions were passed from the periplasmic space across 
the gonococcal inner membrane and into the cytoplasm. To this end, we turned our attention 
to the high-affinity zinc transporter ZnuABC, which has been called MntABC elsewhere in the 
literature due to its ability to also serve as a manganese transporter (105). Many Gram-negative 
bacteria that utilize TdTs also produce ZnuABC (69, 84). We constructed a znuA null mutant and 
 82 
an inducible znuA complemented strain for the purpose of utilizing growth assays to determine 
the contribution of ZnuABC to S100 utilization. We first screened the available S100 proteins for 
growth support in the znuA null mutant, and found that all S100s except S100A4 were defective 
for growth support in this mutant. We did not explore S100A4 further, so explanations for its 
behavior in growth assays are left to speculation. Keeping in mind that it did not show a 
statistically significant ability to support growth of a wild-type gonococcal strain when used as a 
zinc source, it is feasible that S100A4 is a poor zinc chelator, so changes in a gonococcal zinc 
uptake pathway are a poor way to characterize it; unchelated zinc from the initial protein 
loading step could support growth of both FA19 and MCV951. We repeated these growth 
experiments focusing on only S100A7 in order to highlight ZnuABC in the context of TdfJ, and 
confirmed that it no longer supports gonococcal growth in this mutant, suggesting that ZnuABC 
is indeed the method for zinc crossing the inner membrane. We further demonstrated that an 
induced znuA complement recovered the ability to utilize S100A7. From these data, we 
postulate a model wherein TdfJ binds S100A7 at the outer membrane and strips it of its zinc, 
which is passed into the periplasm and subsequently bound by ZnuA, which then uses ZnuBC to 
pass zinc into the cytoplasm.  
 In this report, we define a novel interaction between a gonococcal TdT (TdfJ) and the 
human zinc-binding protein S100A7, wherein TdfJ on the gonococcal surface directly binds 
S100A7 and utilizes if for zinc internalization, thus overcoming one type of host-mediated 
nutrient restriction. This interaction, unique to the human host, may provide a clear selective 
advantage to N. gonorrhoeae in the context of infection, especially at the mucosal epithelium, a 
biologically relevant niche for the gonococcus where S100A7 is enriched (95, 96). Moreover, we 
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show that other S100 proteins support gonococcal growth as a sole zinc source by an as-yet-
unidentified manner. While the mechanism for this is not yet clear, TonB-independent 
siderophore-iron uptake has been observed (33, 79), so this is not unprecedented; ZnuA may 
extract zinc from the S100s assuming they are able to access the periplasm by non-TdT 
mechanisms. In light of these findings, we posit TdfJ as a promising vaccine target for this 
important pathogen. TdfJ is exposed on the bacterial surface and is not subject to the high-
frequency phase and antigenic variation that has disqualified so many other surface structures 
from consideration. It has implications for importance in in vivo survival of the gonococcus by 
utilization of S100A7. Finally, TdfJ is ubiquitously found across the Neisseria, including the 
commensal strains from which gonococci and meningococci frequently acquire resistance 
factors, and which themselves may be opportunistic pathogens (106).  
To summarize, we report a novel interaction between N. gonorrhoeae and its human 
host, which allows the gonococcus to overcome the innate immune mechanism of nutrient 
starvation. Considering the potential importance of this strategy for infection alongside TdfJ’s 
presumed potential as a promising vaccine target, we anticipate further characterization of the 
TdfJ/S100A7 interaction in order to clarify the importance of TdTs as virulence factors for N. 
gonorrhoeae. Presumptive next steps may include characterizing the binding kinetics between 
S100A7 and TdfJ, or identifying key residues within the respective proteins which facilitate 
binding. Cash et al (112) showed that mutagenesis of key residues within TbpA prevented 
binding of transferrin, and reports have shown that mutant, nonbinding surface proteins in 
bacteria may have enhanced immunogenicity (93). With this in mind, a non-S100A7-binding 
mutant of TdfJ could be tested as a potential immunogen worthy of consideration as an 
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ingredient in a hypothetical gonococcal vaccine. Alternatively, therapeutic methods of 
combating active gonococcal infections by targeting TdTs in a manner that limits their ability to 
facilitate metal uptake may be explored as well. Finally, experiments must be performed in 
order to ascertain the conditions in which the gonococcus accesses S100A7 during infection, if 
it does so at all. Although S100A7 is produced in the mucosal epithelia, which is a biologically 
relevant environment as concerns gonococcal infection, we have not yet investigated the in 
vivo significance of the TdfJ/S100A7 interaction. It is anticipated that these experiments will be 
done in the near future. 
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